ARCHIVES

FDA Approves Aranesp For Chemo-Induced Anemia

This article is from The Cancer Letter archive.

Vol. 25 No. 8 | August 30, 2002

Download PDF Visit The Full Archive

Related Articles

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Clinton Proposes Increase For Science And Technology.

February 4, 2000

$20 Million In Construction Funds Approved

April 2, 1976

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993